Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents
Volume: 21, Issue: 11, Pages: 1535 - 1537
Published: Aug 17, 2021
Abstract
Introduction: There is very limited kn3e safety of COVID-19 vaccines in patients with psoriasis who are being treated with biological agents. We present our experience in 369 patients with moderate-to-severe psoriasis undergoing therapy with anti-IL agents who were vaccinated against...
Paper Details
Title
Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents
Published Date
Aug 17, 2021
Volume
21
Issue
11
Pages
1535 - 1537
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History